About ObsEva SA

Company Description

Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.

Year founded

2012

Served area

Worldwide

Headquarters

Chemin des Aulx 12, 1228 Plan-les-Ouates – Switzerland

Shareholder information

Shares outstanding

108,620,471

IPO

July 13, 2018

Stock exchange(s)

SIX Swiss Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.